Skip to main content
. 2020 Mar 1;21(2):80–86. doi: 10.5152/TurkThoracJ.2019.18135

Table 3.

Changes in FEV1 values at baseline and at 12 months

GOLD Status Non-Quitter Quitter


n Baseline 12-month Δ, L p n Baseline 12-month Δ, L p
Stage-0 36 3.14±0.79 3.05±0.78 −0.08 <0.001 29 3.08±0.73 3.18±0.72 +0.10 <0.001
Stage-I 14 2.62±0.65 2.55±0.64 −0.07 <0.001 5 2.94±0.68 3.05±0.69 +0.11 <0.001
Stage-II 11 1.88±0.49 1.82±0.50 −0.06 <0.001 10 2.02±0.63 2.11±0.62 +0.09 <0.001
Stage-III 8 0.96±0.27 0.92±0.28 −0.04 0.10 9 1.00±0.14 1.08±0.13 +0.08 <0.001
Stage-IV 11 0.65±0.13 0.61±0.14 −0.04 <0.001 15 0.62±0.13 0.71±0.15 +0.09 <0.001
Total 80 2.32±1.14 2.24±1.12 −0.08 <0.001 68 2.10±1.19 2.19±1.20 +0.09 <0.001

Mean (median)±SD; Δ, change; L: liters